• Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=8026879).
  

PubMed=7083162
Daniel L. Dexter, George M. Matook, Patricia A. Meitner, Hendrik A. Bogaars, Grant A. Jolly, Michael D. Turner, Paul Calabresi;
Establishment and characterization of two human pancreatic cancer cell lines tumorigenic in athymic mice.
Cancer Res. 42:2705-2714(1982)

PubMed=8026879; DOI=10.1002/ijc.2910580207
Georgina Berrozpe, James Schaeffer, Miguel Angel Peinado, Francisco X. Real, Manuel Perucho;
Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer.
Int. J. Cancer 58:185-191(1994)

PubMed=9665481; DOI=10.1016/S0002-9440(10)65561-7; PMCID=PMC1852940
Rosanna Paciucci, Maya R. Vila, Teresa Adell, Victor M. Diaz, Montserrat Tora, Toshikazu Nakamura, Francisco X. Real;
Activation of the urokinase plasminogen activator/urokinase plasminogen activator receptor system and redistribution of E-cadherin are associated with hepatocyte growth factor-induced motility of pancreas tumor cells overexpressing Met.
Am. J. Pathol. 153:201-212(1998)